These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1903215)

  • 1. Erythropoietin--trials then tribulation.
    Stewart WK
    Scott Med J; 1991 Feb; 36(1):3-4. PubMed ID: 1903215
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis.
    Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Hörl WH; Schollmeyer P
    Nephron; 1989; 53(1):91-2. PubMed ID: 2779711
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of recombinant human erythropoietin on anemia and dialysis: efficiency in patients undergoing CAPD.
    Schollmeyer P; Lubrich-Birkner I; Steinhauer HB
    Contrib Nephrol; 1990; 87():95-104. PubMed ID: 2093545
    [No Abstract]   [Full Text] [Related]  

  • 5. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin may improve the ultrafiltration in peritoneal dialysis: a case report.
    Gloor HJ; Tosi G
    Perit Dial Int; 1990; 10(4):306-7. PubMed ID: 2096935
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of human recombinant erythropoietin on dialysis efficiency in CAPD.
    Steinhauer HB; Lubrich-Birkner I; Schollmeyer P
    Contrib Nephrol; 1991; 89():214-23. PubMed ID: 1909946
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible relation between restless legs and anaemia in renal dialysis patients.
    Roger SD; Harris DC; Stewart JH
    Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
    [No Abstract]   [Full Text] [Related]  

  • 10. A star rises, another fades.
    Neumann ME
    Nephrol News Issues; 2013 Jul; 27(8):8. PubMed ID: 23926618
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of recombinant human erythropoietin on growth hormone responses to growth hormone releasing hormone in uremic patients.
    Díez JJ; Iglesias P; Selgas R
    Clin Nephrol; 1994 Feb; 41(2):119. PubMed ID: 8004829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
    Besarab A; Erslev AJ
    ASAIO J; 1993; 39(2):85-6. PubMed ID: 8324265
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
    N Engl J Med; 1987 Jul; 317(4):249-51. PubMed ID: 3600716
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD.
    Steinhauer HB
    Adv Exp Med Biol; 1989; 260():157-65. PubMed ID: 2624242
    [No Abstract]   [Full Text] [Related]  

  • 19. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.